Biocon has raised Rs 600 crore through Commercial Papers (CPs) on private placement basis. Maturity of the said Commercial Papers will be on September 30, 2025.
Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services.